Expert Opinion on Drug Discovery, Volume 13, Issue 12 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Discovery, Volume 13, Issue 12 (2018)

See all volumes and issues
Vol 19, 2024 Vol 18, 2023 Vol 17, 2022 Vol 16, 2021 Vol 15, 2020 Vol 14, 2019 Volume 13, 2018 Vol 12, 2017 Vol 11, 2016 Vol 10, 2015 Vol 9, 2014 Vol 8, 2013 Vol 7, 2012 Vol 6, 2011 Vol 5, 2010 Vol 4, 2009 Vol 3, 2008 Vol 2, 2007 Vol 1, 2006
Download citations Download PDFs Download issue

Editorial

Editorial
How far have decision tree models come for data mining in drug discovery?
Verena Schöning & Felix Hammann
Pages: 1067-1069
Published online: 23 Oct 2018
First Page PreviewforHow far have decision tree models come for data mining in drug discovery? | Full Text | References | PDF (323.6 KB)
  • 2051 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Challenges and ethical considerations for using cloned primates for human brain discovery
Alan O. Trounson & Andrew J. French
Pages: 1071-1074
Published online: 25 Oct 2018
First Page PreviewforChallenges and ethical considerations for using cloned primates for human brain discovery | Full Text | References | PDF (404.4 KB)
  • 1927 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Current approaches for choosing feature selection and learning algorithms in quantitative structure–activity relationships (QSAR)
Pathan Mohsin Khan & Kunal Roy
Pages: 1075-1089
Published online: 03 Nov 2018
AbstractforCurrent approaches for choosing feature selection and learning algorithms in quantitative structure–activity relationships (QSAR) | Full Text | References | PDF (1.6 MB)
  • 503 Views
  • 59 CrossRef citations
  • 0Altmetric
Review
An overview of neural networks for drug discovery and the inputs used
Yinqiu Xu, Hequan Yao & Kejiang Lin
Pages: 1091-1102
Published online: 17 Nov 2018
AbstractforAn overview of neural networks for drug discovery and the inputs used | Full Text | References | PDF (1.4 MB)
  • 639 Views
  • 25 CrossRef citations
  • 0Altmetric
Review
Using virtual reality for drug discovery: a promising new outlet for novel leads
Xiao-Huan Liu, Tao Wang, Jian-Ping Lin & Mian-Bin Wu
Pages: 1103-1114
Published online: 20 Nov 2018
AbstractforUsing virtual reality for drug discovery: a promising new outlet for novel leads | Full Text | References | PDF (1.2 MB)
  • 362 Views
  • 11 CrossRef citations
  • 0Altmetric
Review
Developments with 3D bioprinting for novel drug discovery
Aishwarya Satpathy, Pallab Datta, Yang Wu, Bugra Ayan, Ertugrul Bayram & Ibrahim T. Ozbolat
Pages: 1115-1129
Published online: 01 Nov 2018
AbstractforDevelopments with 3D bioprinting for novel drug discovery | Full Text | References | PDF (1.9 MB)
  • 474 Views
  • 31 CrossRef citations
  • 0Altmetric
Review
Animal models used to assess influenza antivirals
Edin J. Mifsud, Celeste MK Tai & Aeron C. Hurt
Pages: 1131-1139
Published online: 30 Oct 2018
AbstractforAnimal models used to assess influenza antivirals | Full Text | References | PDF (718.2 KB)
  • 1177 Views
  • 14 CrossRef citations
  • 0Altmetric
Review
Chromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer’s disease
Carlos F. M. Silva, Diana C. G. A. Pinto & Artur M. S. Silva
Pages: 1141-1151
Published online: 15 Nov 2018
AbstractforChromones: privileged scaffolds for the production of multi-target-directed-ligand agents for the treatment of Alzheimer’s disease | Full Text | References | PDF (1.8 MB)
  • 132 Views
  • 11 CrossRef citations
  • 0Altmetric

Special Report

Article
Yeast: bridging the gap between phenotypic and biochemical assays for high-throughput screening
Paul W. Denny
Pages: 1153-1160
Published online: 16 Oct 2018
AbstractforYeast: bridging the gap between phenotypic and biochemical assays for high-throughput screening | Full Text | References | PDF (653.3 KB)
  • 204 Views
  • 12 CrossRef citations
  • 0Altmetric

Drug Discovery Case History

Article
Preclinical discovery and development of colesevelam for the treatment of type 2 diabetes
Henriette Holst Nerild, Mikkel Bring Christensen, Filip Krag Knop & Andreas Brønden
Pages: 1161-1167
Published online: 23 Oct 2018
AbstractforPreclinical discovery and development of colesevelam for the treatment of type 2 diabetes | Full Text | References | PDF (738 KB)
  • 183 Views
  • 8 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

What impact does tautomerism have on drug discovery and development?
Devendra K. Dhaked et al.
Editorial | Published online: 16 Jul 2024
Free Access
Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
Leticia Manen-Freixa et al.
Review Article | Published online: 14 Jul 2024
Inhibitors and PROTACs of CDK2: challenges and opportunities
Yangjie Zeng et al.
Review Article | Published online: 12 Jul 2024
How to correctly develop q-RASAR models for predictive cheminformatics
Arkaprava Banerjee et al.
Editorial | Published online: 5 Jul 2024
Free Access
View all latest articles